A CT segmentation mask can become training data, validation evidence or a clinical decision-support input. That makes its governance different from ordinary image labelling. The risk is not only a bad polygon. It is a bad clinical assumption repeated at scale.
Medical annotation starts with clinical definitions
General annotation guidance often focuses on label quality, reviewer consistency and training data coverage. In healthcare, the first question is clinical: what exactly is being segmented, and for what use?
Organ boundaries, lesions, vessels, nodules and pathology regions require different rules. Slice thickness, contrast, artefacts and scan protocol can affect interpretation. The annotation guideline must therefore reflect both imaging context and model intent.
SBL's radiology segmentation work is positioned around governed CT workflows because the annotation operation has to protect clinical meaning, not just visual accuracy.
Reviewer authority must be explicit
A medical AI dataset should define who can annotate, who can review, who can adjudicate disagreement and when a case should be excluded. Without those rules, the dataset may contain unresolved clinical ambiguity disguised as ground truth.
This is especially important when multiple annotators work across high volumes. The workflow should capture reviewer identity, version history, disagreement categories and final approval status.
That evidence matters later when model performance is questioned. The team can trace whether an error came from image quality, ambiguous anatomy, instruction weakness or model behaviour.
Quality metrics should match clinical risk
Pixel-level agreement is useful, but it does not always reflect clinical usefulness. A small boundary difference may be acceptable in one task and material in another. A missed region may matter more than a slightly overdrawn edge.
QA should therefore combine quantitative measures with clinical review. It should also separate routine errors from high-risk errors, because they do not carry the same downstream consequence.
This is where many annotation programmes under-specify the work. They define a single acceptance number where the project needs a risk-based QA model.
The data package should be audit-ready
A good CT segmentation handover includes masks, source references, modality and protocol context where permitted, annotation guidelines, reviewer logs, QA results, exclusion reasons and version history.
That package allows the model team to train with confidence and allows clinical, compliance or research reviewers to understand the evidence behind the dataset.
For healthcare buyers, the standard should be clear: if the dataset cannot explain how it was made, it is not ready for a serious medical AI workflow.
Questions teams ask before they start
What is CT segmentation?
It is the marking of anatomical structures or regions of interest in CT scans so models or analysts can interpret them consistently.
Why is medical annotation different from ordinary image annotation?
Clinical definitions, patient-safety implications and reviewer authority make the data higher risk and more evidence-dependent.
What evidence should a CT segmentation dataset include?
It should include guidelines, reviewer history, QA results, source references, exclusion logic and version control.